Volume 16, Issue 4 , Pages 271-278, October 2006
BST-CarGel: In Situ ChondroInduction for Cartilage Repair
The repair of articular cartilage has posed a longstanding orthopedic challenge. The concept of marrow stimulation is basically the intentional injury of a subchondral bone below a cartilage lesion to elicit a wound repair response. However, the desire to fill the lesion with a blood clot is at odds with platelet-driven clot retraction, which results in clot shrinkage and detachment. Therefore, BST-CarGel was developed to produce a physically stabilized blood clot that is more voluminous and adherent within a debrided cartilage lesion having access to bone marrow, thus improving existing bone marrow-stimulation procedures. BST-CarGel is a soluble polymer scaffold containing the polysaccharide chitosan, which is dispersed throughout uncoagulated whole blood, and then delivered to a surgically prepared lesion. BST-CarGel allows normal clot formation, reinforces the clot, impedes retraction, increases adhesivity, and ensures prolonged residency of both the clot and critical tissue repair factors from blood. In animals, BST-CarGel was shown to increase the volume and hyaline character of repair tissue, with increased GAG and collagen content, compared with microfracture controls. A patient cohort received BST-CarGel treatment, which encompassed the spectrum of traumatic to degenerative lesions, along with other joint pathologies. Anecdotal evidence demonstrated the potential of BST-CarGel for treating focal cartilage lesions of variable etiology through both mini-open and arthroscopic approaches. Because it requires only a single minimally invasive intervention, BST-CarGel and its unique characteristics are novel in orthopedics. In addition, its use with marrow stimulation provides familiarity with well-recognized surgical techniques, bringing a simple-yet-versatile treatment modality that applies scaffold-guided regenerative medicine to a potentially wide-ranging group of indications.
Keywords: cartilage repair, implant, arthroscopy, scaffold, chitosan, osteoarthritis
To access this article, please choose from the options below
The authors acknowledge funding sources for animal studies, which include BioSyntech Canada Inc, Canadian Institutes of Health Research (CIHR), Canadian Arthritis Networks of Centres of Excellence (CAN), and Canada Research Chairs (CRC).
PII: S1048-6666(06)00072-3
doi:10.1053/j.oto.2006.08.001
© 2006 Elsevier Inc. All rights reserved.
Volume 16, Issue 4 , Pages 271-278, October 2006
